uniQure N.V. (QURE) stock
QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30208% above fair value
$19.35−0.88 (-4.35%)
Close on Nov 20, 2026Market cap $1.34BP/E –Yield –
uniQure revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
uniQure's revenue for the twelve months ending Jun 30, 2026 was $18.67M, up 30.2% year over year. For fiscal 2025 it was $16.10M, down 40.6% from the year before. Over ten years it grew 4.3% a year on average. The highest annual figure on record is $524.00M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.10M | -40.6% |
| FY2024 | Dec 31, 2024 | $27.12M | +71.2% |
| FY2023 | Dec 31, 2023 | $15.84M | -85.1% |
| FY2022 | Dec 31, 2022 | $106.48M | -79.7% |
| FY2021 | Dec 31, 2021 | $524.00M | +1296.8% |
| FY2020 | Dec 31, 2020 | $37.51M | +415.2% |
| FY2019 | Dec 31, 2019 | $7.28M | -35.5% |
| FY2018 | Dec 31, 2018 | $11.28M | -13.9% |
| FY2017 | Dec 31, 2017 | $13.11M | -47.8% |
| FY2016 | Dec 31, 2016 | $25.10M | +137.3% |
| FY2015 | Dec 31, 2015 | $10.58M | +72.3% |
| FY2014 | Dec 31, 2014 | $6.14M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.84M | +11.0% |
| Q1 FY2026 | Mar 31, 2026 | $3.56M | +127.3% |
| Q4 FY2025 | Dec 31, 2025 | $5.57M | +6.6% |
| Q3 FY2025 | Sep 30, 2025 | $3.70M | +61.8% |
| Q2 FY2025 | Jun 30, 2025 | $5.26M | -52.7% |
| Q1 FY2025 | Mar 31, 2025 | $1.57M | -81.5% |
| Q4 FY2024 | Dec 31, 2024 | $5.22M | -21.9% |
| Q3 FY2024 | Sep 30, 2024 | $2.29M | +62.5% |
| Q2 FY2024 | Jun 30, 2024 | $11.13M | +359.4% |
| Q1 FY2024 | Mar 31, 2024 | $8.49M | +59.3% |
| Q4 FY2023 | Dec 31, 2023 | $6.69M | -93.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.41M | -2.9% |
| Q2 FY2023 | Jun 30, 2023 | $2.42M | +387.3% |
| Q1 FY2023 | Mar 31, 2023 | $5.33M | +197.2% |
| Q4 FY2022 | Dec 31, 2022 | $102.75M | +78.1% |
| Q3 FY2022 | Sep 30, 2022 | $1.45M | -27.1% |
| Q2 FY2022 | Jun 30, 2022 | $497.00K | -99.9% |
| Q1 FY2022 | Mar 31, 2022 | $1.79M | +294.7% |
| Q4 FY2021 | Dec 31, 2021 | $57.69M | +69.3% |
| Q3 FY2021 | Sep 30, 2021 | $1.99M | +11.2% |
| Q2 FY2021 | Jun 30, 2021 | $463.87M | +30119.4% |
| Q1 FY2021 | Mar 31, 2021 | $454.00K | +336.5% |
| Q4 FY2020 | Dec 31, 2020 | $34.09M | +1198.5% |
| Q3 FY2020 | Sep 30, 2020 | $1.79M | +71.0% |
| Q2 FY2020 | Jun 30, 2020 | $1.54M | -38.0% |
| Q1 FY2020 | Mar 31, 2020 | $104.00K | -90.8% |
| Q4 FY2019 | Dec 31, 2019 | $2.63M | +63.2% |
| Q3 FY2019 | Sep 30, 2019 | $1.05M | -66.8% |
| Q2 FY2019 | Jun 30, 2019 | $2.47M | -18.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.14M | -67.3% |
| Q4 FY2018 | Dec 31, 2018 | $1.61M | -37.8% |
| Q3 FY2018 | Sep 30, 2018 | $3.15M | +39.3% |
| Q2 FY2018 | Jun 30, 2018 | $3.05M | -38.3% |
| Q1 FY2018 | Mar 31, 2018 | $3.48M | +4.7% |
| Q4 FY2017 | Dec 31, 2017 | $2.58M | -71.7% |
| Q3 FY2017 | Sep 30, 2017 | $2.26M | -68.7% |
| Q2 FY2017 | Jun 30, 2017 | $4.94M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.32M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.13M | – |
| Q3 FY2016 | Sep 30, 2016 | $7.22M | – |
See a number that looks wrong?